363 related articles for article (PubMed ID: 29143286)
1. Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.
Langford D; Oh Kim B; Zou W; Fan Y; Rahimain P; Liu Y; He JJ
J Neurovirol; 2018 Apr; 24(2):168-179. PubMed ID: 29143286
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation.
Fan Y; He JJ
J Biol Chem; 2016 Oct; 291(43):22819-22829. PubMed ID: 27609520
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice expressing HIV-1 envelope protein gp120 in the brain as an animal model in neuroAIDS research.
Thaney VE; Sanchez AB; Fields JA; Minassian A; Young JW; Maung R; Kaul M
J Neurovirol; 2018 Apr; 24(2):156-167. PubMed ID: 29075998
[TBL] [Abstract][Full Text] [Related]
4. Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline.
Kim BO; Liu Y; Ruan Y; Xu ZC; Schantz L; He JJ
Am J Pathol; 2003 May; 162(5):1693-707. PubMed ID: 12707054
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat Promotes Lysosomal Exocytosis in Astrocytes and Contributes to Astrocyte-mediated Tat Neurotoxicity.
Fan Y; He JJ
J Biol Chem; 2016 Oct; 291(43):22830-22840. PubMed ID: 27609518
[TBL] [Abstract][Full Text] [Related]
6. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein.
Zou W; Kim BO; Zhou BY; Liu Y; Messing A; He JJ
Am J Pathol; 2007 Dec; 171(6):1923-35. PubMed ID: 18055541
[TBL] [Abstract][Full Text] [Related]
7. HIV Tat Impairs Neurogenesis through Functioning As a Notch Ligand and Activation of Notch Signaling Pathway.
Fan Y; Gao X; Chen J; Liu Y; He JJ
J Neurosci; 2016 Nov; 36(44):11362-11373. PubMed ID: 27807176
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression.
Vartak-Sharma N; Gelman BB; Joshi C; Borgamann K; Ghorpade A
J Biol Chem; 2014 Jul; 289(28):19599-612. PubMed ID: 24855648
[TBL] [Abstract][Full Text] [Related]
9. Exposure to HIV-1 Tat in brain impairs sensorimotor gating and activates microglia in limbic and extralimbic brain regions of male mice.
Paris JJ; Singh HD; Carey AN; McLaughlin JP
Behav Brain Res; 2015 Sep; 291():209-218. PubMed ID: 26005128
[TBL] [Abstract][Full Text] [Related]
10. Activation of α7 nicotinic acetylcholine receptor ameliorates HIV-associated neurology and neuropathology.
Zhao X; Wilson K; Uteshev V; He JJ
Brain; 2021 Dec; 144(11):3355-3370. PubMed ID: 34196664
[TBL] [Abstract][Full Text] [Related]
11. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates.
Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE
J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110
[TBL] [Abstract][Full Text] [Related]
12. Region-specific effects of HIV-1 Tat on intrinsic electrophysiological properties of pyramidal neurons in mouse prefrontal cortex and hippocampus.
Cirino TJ; Harden SW; McLaughlin JP; Frazier CJ
J Neurophysiol; 2020 Apr; 123(4):1332-1341. PubMed ID: 32101482
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat enhances purinergic P2Y4 receptor signaling to mediate inflammatory cytokine production and neuronal damage via PI3K/Akt and ERK MAPK pathways.
Zhou F; Liu X; Gao L; Zhou X; Cao Q; Niu L; Wang J; Zuo D; Li X; Yang Y; Hu M; Yu Y; Tang R; Lee BH; Choi BW; Wang Y; Izumiya Y; Xue M; Zheng K; Gao D
J Neuroinflammation; 2019 Apr; 16(1):71. PubMed ID: 30947729
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice.
Rademeyer KM; R Nass S; Jones AM; Ohene-Nyako M; Hauser KF; McRae M
J Neurovirol; 2024 Feb; 30(1):1-21. PubMed ID: 38280928
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte activation and dysfunction and neuron death by HIV-1 Tat expression in astrocytes.
Zhou BY; Liu Y; Kim Bo; Xiao Y; He JJ
Mol Cell Neurosci; 2004 Nov; 27(3):296-305. PubMed ID: 15519244
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.
Fatima M; Prajapati B; Saleem K; Kumari R; Mohindar Singh Singal C; Seth P
Glia; 2017 Feb; 65(2):250-263. PubMed ID: 27761954
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression.
Rahimian P; He JJ
J Neuroinflammation; 2016 Sep; 13(1):247. PubMed ID: 27634380
[TBL] [Abstract][Full Text] [Related]
18. Activation of Egr-1 expression in astrocytes by HIV-1 Tat: new insights into astrocyte-mediated Tat neurotoxicity.
Fan Y; Zou W; Green LA; Kim BO; He JJ
J Neuroimmune Pharmacol; 2011 Mar; 6(1):121-9. PubMed ID: 20414733
[TBL] [Abstract][Full Text] [Related]
19. STAT3 and its phosphorylation are involved in HIV-1 Tat-induced transactivation of glial fibrillary acidic protein.
Fan Y; Timani KA; He JJ
Curr HIV Res; 2015; 13(1):55-63. PubMed ID: 25613134
[TBL] [Abstract][Full Text] [Related]
20. Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice.
Bruce-Keller AJ; Turchan-Cholewo J; Smart EJ; Geurin T; Chauhan A; Reid R; Xu R; Nath A; Knapp PE; Hauser KF
Glia; 2008 Oct; 56(13):1414-27. PubMed ID: 18551626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
